These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24655703)

  • 21. Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy.
    Chalil S; Stegemann B; Muhyaldeen SA; Khadjooi K; Foley PW; Smith RE; Leyva F
    Pacing Clin Electrophysiol; 2007 Oct; 30(10):1201-9. PubMed ID: 17897122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction.
    Lieberman R; Padeletti L; Schreuder J; Jackson K; Michelucci A; Colella A; Eastman W; Valsecchi S; Hettrick DA
    J Am Coll Cardiol; 2006 Oct; 48(8):1634-41. PubMed ID: 17045900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial infarction does not preclude electrical and hemodynamic benefits of cardiac resynchronization therapy in dyssynchronous canine hearts.
    Rademakers LM; van Kerckhoven R; van Deursen CJ; Strik M; van Hunnik A; Kuiper M; Lampert A; Klersy C; Leyva F; Auricchio A; Maessen JG; Prinzen FW
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):361-8. PubMed ID: 20495014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapy.
    Jansen AH; Bracke F; van Dantzig JM; Peels KH; Post JC; van den Bosch HC; van Gelder B; Meijer A; Korsten HH; de Vries J; van Hemel NM
    Eur J Echocardiogr; 2008 Jul; 9(4):483-8. PubMed ID: 17826355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Area of left ventricular regional conduction delay and preserved myocardium predict responses to cardiac resynchronization therapy.
    Tse HF; Lee KL; Wan SH; Yu Y; Hoersch W; Pastore J; Zhu Q; Kenknight B; Spinelli J; Lau CP
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):690-5. PubMed ID: 16050824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy.
    Bleeker GB; Kaandorp TA; Lamb HJ; Boersma E; Steendijk P; de Roos A; van der Wall EE; Schalij MJ; Bax JJ
    Circulation; 2006 Feb; 113(7):969-76. PubMed ID: 16476852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy.
    Adelstein EC; Saba S
    Am Heart J; 2007 Jan; 153(1):105-12. PubMed ID: 17174647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multipoint left ventricular pacing improves acute hemodynamic response assessed with pressure-volume loops in cardiac resynchronization therapy patients.
    Pappone C; Ćalović Ž; Vicedomini G; Cuko A; McSpadden LC; Ryu K; Romano E; Saviano M; Baldi M; Pappone A; Ciaccio C; Giannelli L; Ionescu B; Petretta A; Vitale R; Fundaliotis A; Tavazzi L; Santinelli V
    Heart Rhythm; 2014 Mar; 11(3):394-401. PubMed ID: 24291411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Acute Response to Cardiac Resynchronization Therapy by Means of the Misbalance in Regional Left Ventricular Myocardial Work.
    Zweerink A; de Roest GJ; Wu L; Nijveldt R; de Cock CC; van Rossum AC; Allaart CP
    J Card Fail; 2016 Feb; 22(2):133-42. PubMed ID: 26564618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac resynchronization therapy in patients with ischemic versus non-ischemic heart failure: Differential effect of optimizing interventricular pacing interval.
    Marsan NA; Bleeker GB; Van Bommel RJ; Borleffs C; Bertini M; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Am Heart J; 2009 Nov; 158(5):769-76. PubMed ID: 19853696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodality imaging for real-time image-guided left ventricular lead placement during cardiac resynchronization therapy implantations.
    Salden OAE; van den Broek HT; van Everdingen WM; Mohamed Hoesein FAA; Velthuis BK; Doevendans PA; Cramer MJ; Tuinenburg AE; Leufkens P; van Slochteren FJ; Meine M
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1327-1337. PubMed ID: 30847659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving cardiac resynchronization therapy response with multipoint left ventricular pacing: Twelve-month follow-up study.
    Pappone C; Ćalović Ž; Vicedomini G; Cuko A; McSpadden LC; Ryu K; Jordan CD; Romano E; Baldi M; Saviano M; Pappone A; Vitale R; Catalano C; Ciaccio C; Giannelli L; Ionescu B; Petretta A; Fragakis N; Fundaliotis A; Tavazzi L; Santinelli V
    Heart Rhythm; 2015 Jun; 12(6):1250-8. PubMed ID: 25678057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy.
    Chalil S; Foley PW; Muyhaldeen SA; Patel KC; Yousef ZR; Smith RE; Frenneaux MP; Leyva F
    Europace; 2007 Nov; 9(11):1031-7. PubMed ID: 17933857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extent of myocardial viability predicts response to biventricular pacing in ischemic cardiomyopathy.
    Hummel JP; Lindner JR; Belcik JT; Ferguson JD; Mangrum JM; Bergin JD; Haines DE; Lake DE; DiMarco JP; Mounsey JP
    Heart Rhythm; 2005 Nov; 2(11):1211-7. PubMed ID: 16253911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac magnetic resonance-derived anatomy, scar, and dyssynchrony fused with fluoroscopy to guide LV lead placement in cardiac resynchronization therapy: a comparison with acute haemodynamic measures and echocardiographic reverse remodelling.
    Shetty AK; Duckett SG; Ginks MR; Ma Y; Sohal M; Bostock J; Kapetanakis S; Singh JP; Rhode K; Wright M; O'Neill MD; Gill JS; Carr-White G; Razavi R; Rinaldi CA
    Eur Heart J Cardiovasc Imaging; 2013 Jul; 14(7):692-9. PubMed ID: 23175695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy.
    Bleeker GB; Schalij MJ; Van Der Wall EE; Bax JJ
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):899-901. PubMed ID: 16903969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead?
    van Everdingen WM; Zweerink A; Cramer MJ; Doevendans PA; Nguyên UC; van Rossum AC; Prinzen FW; Vernooy K; Allaart CP; Meine M
    Circ Arrhythm Electrophysiol; 2018 Mar; 11(3):e005912. PubMed ID: 29874169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Larger interventricular conduction time enhances mechanical response to resynchronization therapy.
    Padeletti L; Pieragnoli P; Ricciardi G; Perrotta L; Perini AP; Grifoni G; Ricceri I; Padeletti M; Lionetti V; Valsecchi S
    Pacing Clin Electrophysiol; 2013 Apr; 36(4):416-23. PubMed ID: 23305325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT.
    Knappe D; Pouleur AC; Shah AM; Bourgoun M; Brown MW; Foster E; Pfeffer MA; Moss AJ; Solomon SD;
    J Card Fail; 2013 Mar; 19(3):149-55. PubMed ID: 23482074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.